BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10986559)

  • 1. Development of novel simian immunodeficiency virus vectors carrying a dual gene expression system.
    Nakajima T; Nakamaru K; Ido E; Terao K; Hayami M; Hasegawa M
    Hum Gene Ther; 2000 Sep; 11(13):1863-74. PubMed ID: 10986559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
    Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
    Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel lentivirus vector derived from apathogenic simian immunodeficiency virus.
    Stitz J; Mühlebach MD; Blömer U; Scherr M; Selbert M; Wehner P; Steidl S; Schmitt I; König R; Schweizer M; Cichutek K
    Virology; 2001 Dec; 291(2):191-7. PubMed ID: 11878888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells.
    Mangeot PE; Nègre D; Dubois B; Winter AJ; Leissner P; Mehtali M; Kaiserlian D; Cosset FL; Darlix JL
    J Virol; 2000 Sep; 74(18):8307-15. PubMed ID: 10954529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus.
    Schnell T; Foley P; Wirth M; Münch J; Uberla K
    Hum Gene Ther; 2000 Feb; 11(3):439-47. PubMed ID: 10697118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.
    Demaison C; Parsley K; Brouns G; Scherr M; Battmer K; Kinnon C; Grez M; Thrasher AJ
    Hum Gene Ther; 2002 May; 13(7):803-13. PubMed ID: 11975847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus.
    Kobayashi M; Iida A; Ueda Y; Hasegawa M
    J Virol; 2003 Feb; 77(4):2607-14. PubMed ID: 12551999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
    Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
    Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of choroidal neovascularization via brief subretinal exposure to a newly developed lentiviral vector pseudotyped with Sendai viral envelope proteins.
    Murakami Y; Ikeda Y; Yonemitsu Y; Miyazaki M; Inoue M; Hasegawa M; Sueishi K; Ishibashi T
    Hum Gene Ther; 2010 Feb; 21(2):199-209. PubMed ID: 19778186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transduction of the choroid plexus and ependyma in neonatal mouse brain by vesicular stomatitis virus glycoprotein-pseudotyped lentivirus and adeno-associated virus type 5 vectors.
    Watson DJ; Passini MA; Wolfe JH
    Hum Gene Ther; 2005 Jan; 16(1):49-56. PubMed ID: 15703488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
    Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
    J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors.
    Wagner R; Graf M; Bieler K; Wolf H; Grunwald T; Foley P; Uberla K
    Hum Gene Ther; 2000 Nov; 11(17):2403-13. PubMed ID: 11096444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
    Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
    Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuron-specific gene transfer through retrograde transport of lentiviral vector pseudotyped with a novel type of fusion envelope glycoprotein.
    Kato S; Kuramochi M; Takasumi K; Kobayashi K; Inoue K; Takahara D; Hitoshi S; Ikenaka K; Shimada T; Takada M; Kobayashi K
    Hum Gene Ther; 2011 Dec; 22(12):1511-23. PubMed ID: 21806473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
    Bell AJ; Fegen D; Ward M; Bank A
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of second- and third-generation bovine immunodeficiency virus-based gene transfer systems.
    Matukonis M; Li M; Molina RP; Paszkiet B; Kaleko M; Luo T
    Hum Gene Ther; 2002 Jul; 13(11):1293-303. PubMed ID: 12162812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of murine leukemia virus, human immunodeficiency virus, and adeno-associated virus vectors for gene transfer in multiple myeloma: lentiviral vectors demonstrate a striking capacity to transduce low-proliferating primary tumor cells.
    De Vos J; Bagnis C; Bonnafoux L; Requirand G; Jourdan M; Imbert MC; Jourdan E; Rossi JF; Mannoni P; Klein B
    Hum Gene Ther; 2003 Dec; 14(18):1727-39. PubMed ID: 14670124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.
    Dorange F; Piver E; Bru T; Collin C; Roingeard P; Pagès JC
    J Gene Med; 2004 Sep; 6(9):1014-22. PubMed ID: 15352074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.
    Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP
    Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
    Junker U; Böhnlein E; Veres G
    Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.